Market Tracker

04/20 6:02pm ET

Nektar Therapeutics (NASDAQ:NKTR)

10.96
Delayed Data
As of Apr 20
 -0.99 / -8.28%
Today’s Change
10.32
Today|||52-Week Range
17.53
-29.29%
Year-to-Date

Today’s Trading

Previous close11.95
Today’s open11.98
Day’s range10.94 - 11.98
Volume1,962,205
Average volume (3 months)1,433,392
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)-8.06%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book43.16

Competitors

 Today’s
change
Today’s
% change
PRAHPRA Health Sciences ...+0.18+0.65%
ARIAARIAD Pharmaceutical...+0.05+0.56%
FGENFibroGen Inc-0.30-1.04%
INCRINC Research Holding...-0.15-0.49%
Data as of 3:59pm ET, 04/20/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts